Cryopreservation impact on blood progenitor cells: Influence of diagnoses, mobilization treatments, and cell concentration

Transfusion

Volumn 51, Issue 4, 2011, Pages 799-807

  Majado, Maria J ^a,b   Salgado Cecilia, Gema ^a   Blanquer, Miguel ^a   Funes, Consuelo ^a   González García, Consuelo ^a   Insausti, Carmen L ^a   Parrado, Antonio ^a   Morales, Alfonso ^a   Minguela, Alfredo ^a   Moraleda, José M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CD34 SELECTION; CELL COUNT; CELL VIABILITY; CHILD; COLONY FORMING UNIT GM; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FREEZE THAWING; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; SCHOOL CHILD; STEM CELL MOBILIZATION;

EID: 79954583068     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02885.x     Document Type: Article

References (30)

1. Zhao J, Hao HN, Thomas RL, Lyman WD,. An efficient method for the cryopreservation of fetal human liver hematopoietic progenitor cells. Stem Cells 2001; 19: 212-18. (Pubitemid 32524542)
2. Fietz T, Reufi B, Mücke C, Thiel E, Knauf WU,. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts? Hematother Stem Cells Res 2002; 11: 429-35. (Pubitemid 34309537)
3. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, Niederwieser D,. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2010 doi:10.1038/bmt.2010.69.
4. Reich-Slotky R, Colovai AI, Semidei-Pomales M, Patel N, Cairo M, Jhang J, Schwartz J,. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Vox Sang 2008; 94: 351-7. (Pubitemid 351535728)
5. Lee S, Kim S, Kim H, Baek EJ, Jin H, Kim J, Kim HO,. Post-thaw viable CD34+ cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation. Vox Sang 2008; 94: 146-52.
6. Beaujean F, Bourhis J-H, Bayle CH, Jouault H, Divine M, Rieux C, Janvier M, Le Forestier Ch, Pico JL,. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameter on cell recovery and engraftment. Bone Marrow Transplant 1998; 22: 1091-6. (Pubitemid 28554219)
7. Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, Sato K, Klein JP, Gale RP,. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant 1999; 23: 395-6. (Pubitemid 29105964)
8. Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, Buchbarker DM, Yeager AM,. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy 2002; 4: 157-63. (Pubitemid 34537335)
9. Abrahamsen JF, Wentzel-Larsen T, Bruserud O,. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg. Cytotherapy 2004; 6: 356-62. (Pubitemid 39214055)
10. Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, Rapatel C, Berger M, Travade P, Angielski S, Bonhomme J, Deméocq F,. Uncontrolled-rate freezing and storage at -80°C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001; 41: 667-73. (Pubitemid 32845010)
11. Perez-Oteyza J, Bornstein R, Corral M, Hermosa V, Alegre A, Torrabadella M, Ramos P, Garcia J, Odriozola J, Navarro JL,. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study. Haematologica 1998; 83: 1001-5. (Pubitemid 29039470)
12. Areman EM, Sancher RA, Deeg HJ,. Processing and storage of human bone marrow: a survey of current practices in North America. Bone Marrow Transplant 1990; 6: 203-9. (Pubitemid 20333008)
13. Yang H, Acker JP, Cabuhat M, Letcher B, Larratt L, McGann LE,. Association of post-thaw viable CD34+ cell and CFU-GM with time to hematopoietic engraftment. Bone Marrow Transplant 2005; 35: 881-7. (Pubitemid 40667630)
14. Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, Sutherland DR, Chin-Yee IH,. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967-72. (Pubitemid 34845951)
15. Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP,. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2008; 14: 116-24. (Pubitemid 350286748)
16. Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN,. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 2004; 18: 1085-92. (Pubitemid 38786967)
17. Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Ansell SM, Micallef IN, Markovic SN,. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291-8. (Pubitemid 38256560)
18. Humper A, Riggert J, Vehmeyer K, Troff C, Hiddemann W, Köhler M, Wörmann B,. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997; 37: 1050-57. (Pubitemid 27459591)
19. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I,. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-26.
20. Pike BL, Robinson WA,. Human bone marrow growth in agar-gel. J Cell Physiol 1970; 76: 77-84.
21. Moezzi L, Pourfathollah AA, Alimoghaddam K, Soleimani M, Ardjmand AR,. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplant Proc 2005; 37: 4500-3. (Pubitemid 43016065)
22. Valeri CR, Pivacek LE,. Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells. Transfusion 1996; 36: 303-8. (Pubitemid 26141053)
23. Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, Bensinger WI,. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003; 31: 1043-51. (Pubitemid 36722419)
24. Rowley SD, Bensinger WI, Gooley TA, Buckner CD,. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-6. (Pubitemid 24135868)
25. Kudo Y, Minegishi M, Itoh T, Miura J, Saito N, Takahashi H, Suzuki A, Narita A, Sato Y, Kameoka J, Imaizumi M, Sato M, Murakawa Y, Tsuchiya S,. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved by a simple controlled-rate freezing method. Tohoku J Exp Med 2005; 205: 37-43. (Pubitemid 40260053)
26. Sartor M, Antonenas V, Garvin F, Webb M, Bradstock KF,. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products. Bone Marrow Transplant 2005; 36: 199-204. (Pubitemid 41136291)
27. Fu SQ, Abboud CN, Brennan JK, Ifthikharuddin JJ, Nichols D, Liesveld JL,. Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation. Blood Cells Mol Dis 2002; 28: 315-21.
28. Martin-Henao GA, Torrico C, Azqueta C, Amill B, Querol S, Garcia J,. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation. Tranfusion 2005; 45: 1917-24. (Pubitemid 43971418)
29. Foîs E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, Fermand JP, Arnulf B, Mounier N, Ertault M, Lotz JP, Galicier L, Raffoux E, Benbunan M, Marolleau JP, Larghero J,. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 2007; 40: 831-5. (Pubitemid 350020316)
30. Fleming KK, Hubel A,. Cryopreservation of hematopoietic stem cells: emerging science, technology and issues. Transfus Med Hemother 2007; 34: 268-75. (Pubitemid 47236988)